Stereotactic Radiosurgery Using Gamma Rays
Customize your policy alerts
Sign up for CareFirst Policy 6.01.043 alerts
Get alerted when Policy 6.01.043 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity and investigational uses of stereotactic radiosurgery using cobalt-60 gamma rays (e.g., Gamma Knife®) for intracranial and select extra‑cranial indications and governs CareFirst coverage for affected members and providers.
CareFirst has adopted the position of MCG Care Guidelines® and retired this policy, directing readers to the MCG site for medical necessity criteria.
The medically necessary indications were revised in 2023 to add epilepsy and to broaden the experimental/investigational statement to 'all other uses' rather than calling out chronic pain specifically.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.